Invitrogen™ LZTS2 Polyclonal Antibody

Rabbit Polyclonal Antibody

Supplier:  Invitrogen™ PA544945

Catalog No. PIPA544945

Description

Peptide sequence: EPLCPAVPPR KAVPVTSFTY INEDFRTESP PSPSSDVEDA REQRAHNAHL Sequence homology: Cow: 100%; Dog: 100%; Goat: 100%; Guinea Pig: 93%; Horse: 100%; Human: 100%; Mouse: 100%; Pig: 100%; Rabbit: 100%; Rat: 100%.

LZTS2 is a negative regulator of katanin-mediated microtubule severing and release from the centrosome. LZTS2 is required for central spindle formation and the completion of cytokinesis.

Specifications

• Antigen: LZTS2
• Classification: Polyclonal
• Conjugate: Unconjugated
• Gene: LZTS2
• Gene Alias: BC014695; HAMAP-Rule:MF_03026}; hLZTS2; KIAA1813; LAPSER1; Leucine zipper putative tumor suppressor 2; leucine zipper putative tumor suppressor 2 {ECO:0000255; leucine zipper tumor suppressor 2; leucine zipper, putative tumor suppressor 2; LOW QUALITY PROTEIN: leucine zipper putative tumor suppressor 2; Lzts2; mKIAA1813; Protein LAPSER1; putative tumor suppressor LAPSER1; RP11-108L7.8
• Host Species: Rabbit
• Purification Method: Affinity Chromatography
• Regulatory Status: RUO
• Gene ID (Entrez): 84445
• Content And Storage: -20°C, Avoid Freeze/Thaw Cycles
• Form: Liquid

• Applications: Western Blot
• Concentration: 0.5 mg/mL
• Formulation: PBS with 2% sucrose and 0.09% sodium azide
• Gene Accession No.: Q9BRK4
• Gene Symbols: LZTS2
• Immunogen: Synthetic peptide directed towards the N-terminal of human LZTS2 (aa 71-120).
• Quantity: 100 μL
• Primary or Secondary: Primary
• Target Species: Human
• Product Type: Antibody
• Isotype: IgG

Safety and Handling

WARNING: Cancer - www.P65Warnings.ca.gov